期刊文献+

乳腺癌组织TLR4蛋白表达及与细胞凋亡和增殖的关系 被引量:2

Expression of TLR4 and its relationship with cell apoptosis and proliferation in breast cancer
原文传递
导出
摘要 目的探讨乳腺癌组织脂多糖受体(TLR4)的表达及其与细胞凋亡和增殖的关系。方法应用免疫组化法检测乳腺癌及相应癌旁组织TLR4、增殖细胞核抗原(PCNA)的表达,TUNEL法检测组织中细胞的凋亡。结果与癌旁组织比较,乳腺癌组织TLR4表达显著升高(P<0.05)。随着乳腺癌患者T分期、N分期、M分期和细胞凋亡增殖比的增加,乳腺癌组织TLR4的表达升高(P均<0.05),乳腺癌组织TLR4表达与癌组织分化程度无关。结论乳腺癌组织TLR4高表达,促进癌细胞的增殖,在乳腺癌的形成过程中起到了重要的作用。 Objective To investigate the expression of TLR4 in breast cancer and their relationship with cell apoptosis and proliferation. Methods The expression of TLR4 and PCNA in cancer tissues and adjacent tissues were assessed by immunohistochemical method and the apoptosis was detected by the TUNEL method. Results The TLR4 expression in cancer tissues was significantly higher than that in adjacent tissues. Expression of TLR4 increased gradually with the progress of T stages, N stages, M stages and the ratio of apoptic index to proliferative index (P〈0.05), but it had no correlation with histological grade. Conclusion TLR4 over expressed in breast cancer can promote cell proliferation, and play an important role in the pathogenesis of human breast cancer.
出处 《中华普通外科学文献(电子版)》 2011年第3期22-24,共3页 Chinese Archives of General Surgery(Electronic Edition)
关键词 乳腺肿瘤 TLR4 PCNA 细胞凋亡 Breast neoplasm TLR4 PCNA Cell apoptosis
  • 相关文献

参考文献5

二级参考文献58

  • 1Medzhitov R,Presto-Hudburt P,Janeway CA.A human homolngue of the drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997,388(3):394-397.
  • 2Pohorak A,He X,Smimova I,et al.Defective LPS signaling in C3H/HeJ and C57BL/10Sccr mice:mutations in Tlr4 gene[J].Science,1998,282(4):2085-2088.
  • 3Pastor CM,Pugin J,Kwak B,et al.Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia[J].Crit Care Med,2004,32(8):1759-1763.
  • 4Shi H,Kokoeva MV,Inouye K,et al.TLR4 links innate immunity and fatty acid-induced insulin resistance[J].J Clin Invest,2006,116(11):3015-3025.
  • 5Janeway CA,Medzhitov R.Innate immune recognition[J].Annu Rev Immunol,2002,20(5):197-216.
  • 6Bachar O,Adner M,Uddman R,et al.Toll-like receptor stimulation induces airway hyoer-responsiveness to bradykinin,an effectmediated by JNK and NF-kappa B signaling pathways[J].Eur J Immunol,2004,34(4):1196-1207.
  • 7Yan ZQ.Regulation of TLR4 expression is a tale about tail arteriosclerosis[J].Thromb Vasc Biol,2006,26(4):2582-2584.
  • 8Gioannini TL,Weiss JP.Regulation of interactions of Gram-negative bacterial endotoxins with manlmalian cells[J].Immunol Res,2007,39(1/3):249-260.
  • 9Erridge c,Moncayo-Nieto OL,Morgan R,et al.Acinetobaeter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signaling[J].J Med Microbiol,2007,56(Pt 2):165-171.
  • 10Calvano JE,Agnese DM,Um JY,et al.Modulation of the lipopolysaccharide receptor complex(CD14,TLR4,MD-2)and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection:relationship to tolerance[J].Shock,2006,20(3):417-419.

共引文献61

同被引文献19

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1469
  • 2薛晓红,刘胜,杨新伟,陆德铭.乳宁冲剂及拆方对裸鼠移植瘤生长及肺转移的影响[J].上海中医药杂志,2005,39(7):45-47. 被引量:10
  • 3阙华发,陈红风,高尚璞,陆德铭,唐汉钧,贾喜花,徐杰男.乳宁Ⅱ号防治乳腺癌MDA-MB-435裸鼠移植瘤生长转移作用及其抑制血管生成的机制研究[J].中国中医基础医学杂志,2007,13(8):592-594. 被引量:8
  • 4Rosa G, Staibano S. p53 protein in aggressive and nonaggressive basal cell carcinoma[ J], J Cutaneous Pathol, 1993, 20 (5) :429 -31,.
  • 5Singh K P, Zarnegar R. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human epithelial cells [ J 1. Am ] Physiol, 1995,268 (6) : L1012 - 20.
  • 6Hirose Y, Kojima M, Sagoh M. Immunohistochemical examination of c-Met protein expression in astrocytic tumors[ J]. Acta Neuro- pathol, 1998,95 (4) :345 - 51.
  • 7Siegfried J M, Weissfeld L A, Luketich J D, et al. The clinical significance of hepatocyte growth factor for non-small cell lung cancer[ J]. J Thorac Surg, 1998,66(6) : 1915 - 8.
  • 8Takeuchl H, Bilchik A, Saha S, et al. C-Met expression level in pri- mary colon cancer [ J ]. Clin Cancer Res, 2003,9 ( 4 ) : 1480 - 8.
  • 9Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive hep- atocyte growth factor is a strong and independent predictor of re- currence and survival in human breast cancer [ J]. Cancer Res, 1994,54(7) :1630.
  • 10Sheen-Chen S M, Liu Y W, Eng H L, et aL Serum levels of hep- atocyte growth factor in patients with breast cancer [ J ]. Cancer Epidemiol B iomarkers Prey,2005,14 ( 3 ) : 715 - 7.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部